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Abstract
Recently, an apolipoprotein E–deficient (ApoE–/–) mouse model with a mutation (C1039G+/¡) in the fibrillin-1 (Fbn1) gene
(ApoE–/–Fbn1C1039G+/– mouse model) was developed showing vulnerable atherosclerotic plaques, prone to rupture, in contrast to
the ApoE–/– mouse model, where mainly stable plaques are present. One indicator of plaque vulnerability is the level of macrophage
infiltration. Therefore, this study aimed to measure and quantify in vivo the macrophage infiltration related to plaque development and
progression. For this purpose, 5-weekly consecutive gold nanoparticle–enhanced micro–computed tomography (microCT) scans were
acquired. Histology confirmed that the presence of contrast agent coincided with the presence of macrophages. Based on the microCT
scans, regions of the artery wall with contrast agent present were calculated and visualized in three dimensions. From this information,
the contrast-enhanced area and contrast-enhanced centerline length were calculated for the branches of the carotid bifurcation
(common, external, and internal carotid arteries). Statistical analysis showed a more rapid development and a larger extent of plaques
in the ApoE–/–Fbn1C1039G+/– compared to the ApoE–/– mice. Regional differences between the branches were also observable and
quantifiable. We developed and applied a methodology based on gold particle–enhanced microCT to visualize the presence of mac-
rophages in atherosclerotic plaques in vivo.
C ARDIOVASCULAR DISEASE is the leading cause ofmorbidity and mortality in developed countries,1 with
atherosclerosis often being the underlying cause of myo-
cardial infarction and stroke. Atherosclerosis is a slowly
progressing chronic inflammatory disease of the medium-
size and large arteries and is characterized by the develop-
ment of atherosclerotic plaques. One of the major emerging
clinical challenges is the need to differentiate between vul-
nerable plaques, which are likely to cause embolic stroke on
rupture and thus need immediate treatment, and stable
plaques, which do not cause an immediate threat. Tradi-
tionally, the apolipoprotein E–deficient (ApoE–/–) mouse
model is the most popular mouse model to study athero-
sclerotic plaque at a preclinical stage.2–5 When fed a
Western-type diet, these mice develop stable atherosclerotic
plaques. Recently, ApoE–/–Fbn1C1039G+/– mice have been
described as a novel mouse model for vulnerable plaques and
plaque rupture.6,7 A heterozygous mutation in the fibrillin-1
(Fbn1) gene leads to fragmentation of the elastic fibers in the
artery wall. When fed a Western-type diet, vulnerable plaque
formation occurs, including intraplaque neovascularization,
intraplaque hemorrhage, and plaque rupture.
Both stable and unstable plaques consist of lipids accu-
mulating in the artery wall and are infiltrated bymacrophages
and other inflammatory cells. Since the presence of a high
number of macrophages is one of the indications of a more
severe, unstable plaque phenotype,8 macrophage quantifica-
tion is a main target for molecular small animal imaging
strategies.9 For example, ultrasmall superparamagnetic iron
oxide particles have been used to detect the macrophages
present in plaques with magnetic resonance imaging
(MRI),10–13 and so has the vascular cell adhesion molecule 1.
This molecule has been targeted with superparamagnetic
peptide–functionalized nanoparticles for MRI14,15 and with
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lipid-shelled microbubbles for ultrasound imaging.16 Fur-
thermore [18F]fluorodeoxyglucose (FDG) positron emission
tomography (PET)–computed tomography (CT) has been
used to visualize plaque-related inflammation.17,18
However, the (through-plane) resolution of the used
scanners, mainly MRI and PET, is limited for capturing the
presence of atherosclerotic plaques in the carotid bifurcation
of mice.19 Therefore, plaque imaging is often restricted to
anatomic images obtained by CT in combination with
(iodinated) contrast agents, in which narrowing of the lumen
indicates the presence of a plaque.20 Enhancing anatomic CT
with molecular imaging could help us better understand the
processes taking place in vivo during the formation of
atherosclerotic plaques. For this purpose, N1177, a suspen-
sion of crystalline iodinated particles dispersed with surfac-
tant, has been explored in rabbits.21,22 High-risk,
macrophage-rich atherosclerotic plaques could be detected
with CTresolution, but, unfortunately, the half-life of water-
soluble iodine contrast agents is too short to be used with a
single-bolus injection in mice.23 Accordingly, there is a
need for a high-precision micro–computed tomography
(microCT) scan protocol that allows detection of macro-
phages in murine plaques as a marker of plaque vulnerability.
In the present study, we demonstrated that Aurovist
(Nanoprobes, Yaphank, NY), a recently introduced microCT
contrast agent, can be used as a "tracing marker" for macro-
phages. Aurovist consists of 15 nm gold particles with a poly-
ethylene glycol coating, which increases its circulation time by
partially switching its elimination pathways from the reticu-
loendothelial system to the mononuclear phagocyte system.
Details on the mechanism of action and the biodistribution of
the contrast agent are found elsewhere.23–26 ApoE–/– mice,
developing stable plaques, and ApoE–/–Fbn1C1039G+/– mice,
developing vulnerableplaques,were injectedwithAurovist and
scanned with microCT at three consecutive time points. The
animals were sacrificed, and dissected carotid arteries were
investigated with histology, confirming that Aurovist is pha-
gocytized by macrophages that accumulate within the ather-
osclerotic plaque. Furthermore, we propose a novel
methodology to quantify Aurovist/macrophage accumulation
invivo, along the carotid bifurcation.A significant difference in
macrophage accumulationwas foundbetweenmicewith stable
and mice with vulnerable plaques.
Materials and Methods
Mice
FemaleApoE–/–Fbn1C1039G+/–mice7 (n=14) and theirApoE–/–
littermates (n = 9; 6 weeks old) were fed a Western-type
diet (TD88137, Harlan Teklad, Madison, WI) for up to 20
weeks. The mice were kept under environmentally controlled
conditions (12-hour normal light/dark cycles, 20–23C, and
50% relative humidity) with food and water ad libitum.
They were housed in groups of four to eight animals in well-
ventilated cages with appropriate cage enrichment. All
experiments were conducted according to the European
Commission guidelines and were approved by the Animal
Ethics Committee of Ghent University.
In Vivo Imaging at Weeks 10, 15, and 20
The animals underwent contrast-enhanced microCTscans at
weeks 10, 15, and 20 after the start of the diet. Anesthesia was
induced using a mixture of medical oxygen and 5% iso-
flurane and was reduced to 1 to 1.5% during the scanning.
A first microCT scan (termed the precontrast microCT
measurement) (Figure 1A) was acquired using a Triumph-II
imaging system (TriFoil Imaging, Chatsworth, CA). After
this measurement, the animal bed was moved out of the
scanner and 100 mL/25 g body weight Aurovist was injected27
in the tail vein through a previously inserted catheter to
avoid animal movement. Immediately after this injection,
the animal was translated back to its initial position in the
scanner and a postcontrast microCTmeasurement was taken
(Figure 1B). The microCT scan settings were set to a 50 mm
focal spot size, 50 mm detector pixel size, 1,024 projections,
3.5 times magnification, 500 mA tube current, 75 kVp tube
voltage, and a continuous rotation mode. The acquisition
region of interest spanned the entire volume between the
root of the aorta and approximately half of the skull.
Histologic Examination
After euthanasia or sudden death, mice were dissected and
the aorta (including the brachiocephalic and carotid arter-
ies) was isolated. Arteries were fixed in 4% formaldehyde
(pH 7.4) for 24 hours, processed, and embedded in paraffin.
Histologic analysis was performed on serial cross sections
(5 mm) of the proximal ascending aorta and brachiocephalic
and carotid arteries. Macrophages were determined by
immunohistochemistry using anti-Mac-3 antibody (Phar-
mingen, San Diego, CA). Secondary antibody was species-
appropriate horseradish peroxidase conjugates (Vector
Laboratories, Burlingame, CA). 3-Amino-9-ethyl-carbazole
(Vector Laboratories) was used as a chromogen. Images were
acquired with Universal Grab 6.1 (IDL) software (Exelis,
Boulder, CO) using an Olympus BX40 microscope (Tokyo,
Japan). Images were quantified using ImageJ software
(National Institutes of Health, Bethesda, MD).
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Segmentation and Image Processing
The Iterative Maximum-likelihood Polychromatic Algo-
rithm for CT28 was used to reconstruct the CT data to reduce
the effect of beam hardening due to the dense skull bone. To
speed up the reconstructions, all data were first recon-
structed at a lower resolution (0.2 mm isotropic voxel size),
after which only the volume of interest around the carotid
arteries was reconstructed at a higher resolution (0.050 mm
isotropic voxel size).29 This method was applied to both the
pre- and postcontrast data sets.
To get rid of misalignments between the pre- and the
postcontrast image, an image registration step was
applied based on the BRAINSFit toolbox30 in 3D Slicer 4
(<http://www.slicer.org>).31 The following parameters were
inserted in the rigid registration algorithm: number of
samples = 300,000; spline grid size = 14, 10, 12; number of
iterations = 1,000; linear interpolations, minimum step
length = 0.000001; number of histogram bins = 200; and
number of matchpoints = 40. The precontrast injection
image was set as the moving image. After automatic regis-
tration, the 3D Slicer checkerboard module was used to
visually inspect the registration results, and if there was a
residual misalignment, the data set was removed from the
database. Subsequently, an angiographic image was con-
structed by subtracting the registered precontrast image
from the postcontrast image (Figure 1C). A vesselness-
enhanced image (Figure 1D) was constructed based on the
angiographic image. To that end, a Frangi vesselness filter
was applied in the Vascular Modeling Toolkit (VMTK;
<http://www.vmtk.org>)32 with the following parameters:
alpha 0.3, beta 500, and gamma 200. For the algorithm, 10
logarithmically spaced steps between 0.05 and 0.5 mm were
taken.
The left and right carotid arteries were segmented with
the levelset segmentation algorithm of VMTK.33 First, an
initial levelset was segmented based on the vesselness-
enhanced image. The common carotid artery (CCA),
external carotid artery (ECA), and internal carotid artery
(ICA) were initially segmented by repeated executions of
the colliding fronts algorithm, which returns a branch of the
vascular network between a source and a target point. The
threshold level was taken to be 40 Hounsfield units (HU) but
manually adapted between 30 and 50 HU to get rid of noise
or nearby veins if needed. The ICA was segmented beyond
the emerging of the stapedial artery (SA), and the first part
of the SA was also segmented (Figure 1E). The ECA was
segmented as far as the bifurcation into the maxillary and
superficial temporal arteries. After the initialization, an evo-
lution step based on the angiographic image was carried out.
The parameters for this step were propagation weight = 1,
Figure 1. Overview of the measured and postprocessed images. Images represent the right carotid bifurcation of an ApoE–/–Fbn1C1039G+/– mouse on
a Western-type diet for 20 weeks. A, The precontrast measured microCT data set where the contrast agent accumulation in the artery wall is clearly
visible around the bifurcation. B, Postcontrast injection image showing the vasculature. C, The angiographic image, constructed by subtracting the
registered precontrast image from the postcontrast image. The vasculature is clearly visible in this image. D, The vesselness-filtered angiographic
image showing higher contrast for the vasculature. This facilitates the initialization of the segmentation process. E, Segmentation of the right carotid
bifurcation depicting the common carotid artery (blue), the external carotid artery (cyan), the first part of the internal carotid artery (green), part of
the stapedial artery (red), and the second part of the internal carotid artery (orange).
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curvature weight = 0.4, advection weight = 0.6, edge
weight = 0, and number of iterations = 200. The resulting
surface was consecutively remeshed, smoothed, and
remeshed again in VMTK to obtain an optimal surface
representation. For the first remeshing, the area of the tri-
angles was taken to be between 500 and 300 mm2. After-
wards, smoothing was performed with a passband of 0.1 and
30 iterations. For the final remeshing, the triangle area
ranged between 150 and 50 mm2. Based on the calculated
centerline, the carotid bifurcation was split in its three
branches (CCA, ECA, and ICA).
Quantifying Macrophage Presence within the Lumen
Area
The next step was to quantify the presence of contrast agent
in the arterial wall on the precontrast images (i.e., with
contrast agent originating from injections at previous time
points). In principle, this is only relevant for data measured
at weeks 15 and 20, but precontrast scans at week 10 were
also processed to serve as controls (because no contrast
should be detected).
To allow a smoother integration, the registered pre-
contrast image was resampled to a resolution of 0.025 mm.
Subsequently, the volume inside the segmented carotid
arteries was masked on the resampled precontrast image
using the vtkImageStencil tool of the Visualization Toolkit
(VTK; <http://www.vtk.org>). The carotid bifurcation
was cut out of the segmented surface by cutting the three
branches based on the length of the ICA (between the carotid
bifurcation and the SA bifurcation). The ICAwas cut at 95%
of its length, the ECA was cut at the point where it reached
the length of the ICA, and the CCA was cut at two times the
length of the ICA. For every triangle of the surface mesh at
the carotid bifurcation, the normal was calculated in pyFormex
(<http://www.nongnu.org/pyformex/>) (Figure 2A). These
normals were uniformly sampled at 100 points over a total
length of 0.3 mm. The sample points were classified to have
an increased intensity, indicating the presence of contrast
agent, if the image intensity was higher than a cutoff
value of 350 HU. Based on the volume mask, we verified
that every point was located outside the artery. Finally, for
every surface triangle, the relative number of selected
high-intensity points on the corresponding normal was
expressed divided by the total amount of points outside the
artery (Figure 2B). Thus, we obtained a clear visual
representation of the presence of contrast agent near the
boundary of the lumen.
Finally, we quantified the results as follows: every surface
element in which more than 25% of the points of its surface
normal had elevated intensity values was categorized to
the increased intensity group, whereas all other elements
were categorized in the normal intensity group. Subse-
quently, for every bifurcation branch (CCA, ECA, and ICA),
the contrast-enhanced area and the contrast-enhanced area
fraction (CAF[%area]), were calculated.
Figure 2. Overview of the differ-
ent steps involved in the quantifi-
cation of the contrast-enhanced
regions. A, This panel shows 1 of
10 calculated normals (black)
perpendicular to the lumen sur-
face (gray). B, The amount of
points along each normal with an
intensity higher than 350 HU
indicates the regions with contrast
agent present. C, The luminal area
is split in rings with an average
width of 0.05 mm to map the
contrast-enhanced regions along
the length of the arteries. D, The
surface zones with contrast agent
present along more than 25% of
the normals are indicated in red.
After the splitting of the lumen
area in rings, a ring was selected to
belong to the contrast-enhanced
group if more than 10% of the
surface showed contrast. The
affected regions of the centerlines
are indicated in red and the unaf-
fected regions in gray.
De Wilde et al4
Quantifying Macrophage Presence along the Centerline
Because the ApoE–/–Fbn1C1039G+/– mice develop a high
degree of stenosis in the carotid arteries over time, only
considering the luminal surface holds the risk of a bias.
Stenosis will reduce the internal area of the artery wall, which
leads to an underestimation of the influence of these regions
when using an area-averaged value. To circumvent this risk,
the contrast-enhanced regions were mapped to the center-
line of the lumen because the centerline length is not affected
by the presence of stenosis. For this operation, the centerline
was calculated, resampled to 0.05 mm, and split into
branches in VMTK. For every segment of the centerline, the
corresponding part of the luminal wall was selected in
pyFormex by cutting the entire luminal surface with two
planes, thus splitting the total geometry into rings with an
average width of 0.05 mm (Figure 2C). Again, we categorized
the data and considered each segment to belong to the
contrast group if the outer contrast-enhanced lumen area in
the corresponding ring segment was more than 10% of the
total lumen ring segment area (Figure 2D). Similar to the
method proposed by Brown and colleagues with regard to
calcification of plaques,34 we were thus able to track the
presence of contrast agent along the centerline. Finally, we
calculated for every branch for what distance along the
centerline contrast agent was present (contrast-enhanced
length fraction, CLF [%length]).
Statistical Analysis
The same statistical analysis was performed for the CAF
[%area] and CLF[%length]. Genotype was taken as a between-
subjects factor because the mice were grouped accordingly
(ApoE–/– or ApoE–/–Fbn1C1039G+/–). In addition, the mea-
sured data set was split by three within-subjects factors,
namely, time (week 15 or week 20), side (left or right carotid
bifurcation), and location (CCA, ECA, or ICA). The mea-
surements at week 10 were used to validate the process and
did not receive a contrast injection at a previous time point;
therefore, these measurements were not included in this
analysis. The statistical analysis was performed in SPSS
Statistics 22 (IBM, Armonk, NY). The preferred test for this
type of data set is the general linear model with repeated
measures. However, for this test, only the subjects (mice) for
whom all measurements are available are taken into account,
which reduced the data set to three ApoE–/– and six
ApoE–/–Fbn1C1039G+/– mice. Hence, we decided to use a
linear mixed model in which the within-subjects variables
are included as repeated measurements. This test can handle
missing values, so no measured data were excluded. We
opted for an autoregressive heterogeneous covariance
structure for the residuals after minimizing the information
criteria for different covariance structures. A random effect,
with scaled identity as covariance type and including the
intercept, was added for the mice identities to account for
the random mice selection out of the population for this
study. Next, a type III type of sum of squares was chosen.
Finally, a full factor analysis was performed for the four
factors: strain, time, side, and location.
To verify the operator independence of the proposed
methodology, the operator-dependent segmentation step
was performed (blinded) by a second operator. From this
second set of segmentations, further operator-independent
processing steps resulted in a new set of CAF and CLF values.
The correlation between the results of both operators for
CAF and CLF was calculated as we tested for equivalence of
the average values of both data sets using a two one-sided
paired t-tests approach35 (Microsoft Excel).
Results
Available Data Sets for Analysis
One ApoE–/– and two ApoE–/–Fbn1C1039G+/– mice died or
were euthanized for ethical reasons before they reached week
10 of the diet. Signs of severe pain and distress, which led to
the euthanasia, included panting, head tilt, a hunched body
posture, and immobility. Therefore, at the first imaging
time point, 8 ApoE–/– and 12 ApoE–/–Fbn1C1039G+/– mice
were still included in the study. Afterwards, 4 more
ApoE–/–Fbn1C1039G+/– died or were euthanized before the
end of the experiment. Two measurements failed because of
a human error. Next to this, in six cases, the registration of
the pre- and postcontrast images failed due to motion arti-
facts. Finally, only a portion of the right ECA of two ApoE–/–
mice at week 20 could be resolved, due to severe stenosis, and
only the left carotid bifurcation was thus included at this
time point. In summary, the analysis includes 14, 8, and 14
ApoE–/– carotid bifurcations (left and right) at weeks 10, 15,
and 20, respectively. For the ApoE–/–Fbn1C1039G+/– mice, 20,
16, and 14 bifurcations were available for analysis at these
time points.
Histology
As a first step, we investigated whether the injected Aurovist
particles can be used as a tracing marker for macrophage
presence. The Mac-3 stain in Figure 3 shows a representative
example of macrophage infiltration (in red) in different areas
of an atherosclerotic plaque (panels A and B). Aurovist par-
ticles (visible on the Mac-3 stain as black dots) are abundantly
present in macrophage-rich regions (panels C and D) as well
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as in the plaque necrotic cores (panels E and F). We hypo-
thesize that in the hours and days after Aurovist injection,
macrophages phagocytize the Aurovist particles and migrate
to inflamed zones within the plaque. At the necrotic cores,
Aurovist particles accumulate, yet no macrophages can be
detected on the Mac-3 stain. We hypothesize that Aurovist
particles at this location have been released by necrotic
macrophages that are no longer visible on the Mac-3 stain
(loss of epitope). We conclude that Aurovist can be used
in combination with microCT as an in vivo tracer for
macrophage presence.
Validation Test for False Positive Results at Week 10
The results at week 10 served to validate the performance of
the proposed framework with regard to false positives
(contrast-enhanced locations found) as these animals did
not receive any previous contrast injection. The maximum
value for an individual mouse at week 10 of the CAF was
0.15, 1.17, and 0.22 %area for the CCA, ECA, and ICA,
respectively. For the CLF, these values were, respectively,
0.00, 3.36, and 0.00 %length. Averaged over the whole group,
the false positives for the CCA and the ICAwere smaller than
0.02%area/length. For the ECA, the average false positives were
0.077%area and 0.18%length mainly because of the presence of
a tracheal cartilage ring in the image field in one animal.
Both measures are thus reasonably robust but fail in the rare
case that a trachea cartilaginous ring is present in the region
of interest.
Quantification of Contrast Enhancement in the
Arterial Branches: CAF and CLF
Table 1 quantifies the CAF [%area] for every separate branch
of the bifurcation (CCA, ECA, and ICA). In both ApoE–/–
and ApoE–/–Fbn1C1039G+/– mice, the highest contrast agent
uptake occurred in the ECA, at both week 15 and week 20.
In both mouse models, there was an increase over time,
especially in the ApoE–/– model, where a fourfold increase
in contrast uptake between weeks 15 and 20 could be
observed. The increase in the ApoE–/–Fbn1C1039G+/–model
was less pronounced, with a 200% increase for the CCA
Figure 3. A and B, Mac-3 stain showing a representative example of macrophage infiltration in different areas of an atherosclerotic plaque of an
ApoE–/–Fbn1C1039G+/– mouse. Macrophages are stained in red, whereas Aurovist particles are visible as black dots. Aurovist particles are abundantly
present in macrophage-rich regions such as the plaque shoulder as well as in the plaque necrotic cores. C and D, Detailed images show how
macrophages have engulfed Aurovist particles. E and F, In the necrotic cores, Aurovist particles accumulate, yet no macrophages can be detected on
the Mac-3 stain. Scale bars of A and B are 200 mm and scale bars of C–F are 50 mm.
Table 1. CAF [%area] with the Standard Deviation at the Different Branches
ApoE–/– ApoE–/–Fbn1C1039G+/–
CCA ECA ICA CCA ECA ICA
w15 2.77 ± 3.33 12.56 ± 10.32 4.20 ± 2.97 8.02 ± 5.94 40.35 ± 26.53 18.98 ± 15.81
w20 11.70 ± 18.23 51.74 ± 27.68 27.11 ± 24.56 18.05 ± 18.22 64.55 ± 24.16 43.27 ± 20.98
CAF [%area] = contrast-enhanced area fraction; CCA = common carotid artery; ECA = external carotid artery; ICA = internal carotid artery.
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and ICA and a 50% increase in the CCA. This is, however,
mainly due to the already higher extent of contrast agent
uptake at week 15 in the ApoE–/–Fbn1C1039G+/– mice. The
statistical CAF analysis in different branches revealed that
time (week 15–week 20) and location (CCA, ECA, or ICA)
are highly significant factors (p < .01). Genotype (ApoE–/–
or ApoE–/–Fbn1C1039G+/–) has a higher p value but is still a
significant factor (p < .05). No difference was found
between the left or right side (p = .745). Finally, the
interaction between the factors time and location was also
highly significant (p < .01). This supports the trends shown
in Table 1. The estimated averages showed that, on average,
ApoE–/– mice had 14.2%area less contrast-enhanced area
compared to ApoE–/–Fbn1C1039G+/– mice, and this effect
was significant (p < .05). At week 15, the affected area was
smaller than at week 20, with an average difference of
19.6%area (p < .01). The differences between the locations
in both strains were also highly significant (p < .01): the
contrast-enhanced area in the CCA was smaller compared
to that of the ECA (32.3%area) or the ICA (13.6%area).
The results depicted in Table 2 represent the CLF
expressed in %length for the three different branches (CCA,
ECA, and ICA). These results are similar to the results shown
in Table 1. However, the absolute values are higher because
this way of calculating contrast agent accumulation attri-
butes a higher weight to regions where contrast agent is
present only partially around the circumference. These
results are summarized in Figure 4. A marked increase in
Aurovist accumulation can be observed fromweek 15 (cross-
hatched bars) to week 20 (bars without hatching). The sta-
tistical analysis of the CLF yields slightly different results
compared to the CAF. Time and location are still highly
significant (p < .01), but in this case, genotype is also highly
significant. Still, there is no statistical indication of a dif-
ference between left and right (p = .609). Furthermore, the
interaction between time and location remains highly sig-
nificant. Finally, the interaction between genotype and
location, which was almost significant in the CAF, became
significant (p < .05) for the CLF. The ApoE–/– mice have on
average 20.7%length smaller contrast accumulations (p < .01)
compared to ApoE–/–Fbn1C1039G+/– mice. From week 15 to
week 20, the model estimated average growth of the contrast
deposits is 30.5%length. Moreover, the CLF in the CCA is
51.3%length lower compared to the ECA and 32.0%length
lower compared to the ICA (both p < .01). For both the CAF
and the CLF, the statistical tests show that there is a sig-
nificant difference between both groups of mice. We can
conclude that, on average, the ApoE–/–Fbn1C1039G+/– mice
have more contrast accumulation, that there is a significant
growth in accumulation over time, and that it is very loca-
tion dependent.
Testing for Operator Independence
The resulting CAF and CLF values were compared for two
sets of segmentations, executed by two different operators.
The correlation between both CAF data sets is 0.993, and for
the CLF, it is 0.986. The mean difference between both CAF
data sets was smaller than 1%area (p < .001). For CLF, the
mean difference is smaller than 5%length (p < .001).
Qualitative Visualization of the Contrast-Enhanced
Regions
The quantitative results described above are further
illustrated by graphical representations of the precise
Figure 4. The length of the centerline of each branch where contrast
agent is present (CLF) [% cl]. CCA = common carotid artery; ECA =
external carotid artery; ICA = internal carotid artery.
Table 2. CLF [%length] with the Standard Deviation at the Different Branches
ApoE–/– ApoE–/–Fbn1C1039G+/–
CCA ECA ICA CCA ECA ICA
w15 10.23 ± 17.23 40.87 ± 21.75 11.31 ± 10.79 15.78 ± 10.10 75.65 ± 36.17 48.57 ± 34.64
w20 23.51 ± 28.77 82.30 ± 25.61 67.44 ± 33.43 39.34 ± 12.93 95.32 ± 12.77 87.88 ± 17.71
CCA = common carotid artery; CLF [%length] = contrast-enhanced length fraction; ECA = external carotid artery; ICA = internal carotid artery.
Plaque Detection and Quantification with Gold Particle–Enhanced CT 7
contrast-enhanced locations. Figure 5 shows a representative
example of an ApoE–/– mouse at weeks 15 and 20. At week
15, there were only small regions where contrast enhance-
ment was visible. The two largest regions were located in the
ECA. At week 20, the shape of the contrast-enhanced area
had changed, with contrast-enhanced zones at regions of the
ECA, ICA, and CCA close to the bifurcation. In Figure 6,
similar images are shown for an ApoE–/–Fbn1C1039G+/–
mouse at weeks 15 and 20. In this case, the shape of the
contrast-enhanced area was similar for both time points,
with Aurovist present along the entire ECA and ICA and in
the part of the CCA closest to the carotid bifurcation.
However, the contrast-enhanced area was significantly
increased at week 20, confirming the quantitative results
indicated in Table 1.
Precise Locations of Contrast-Enhanced Regions in
Both Groups of Mice
On top of the quantitative and qualitative analysis, the
proposed framework also allows for an exact and detailed
visualization of the locations of Aurovist accumulation. The
first row of Figure 7 (panels A and B) shows the number of
cases for which Aurovist was present in the CCA as a
function of the distance to the bifurcation. The distance is
zero (right side of the x-axis) at the bifurcation and decreases
downstream from there. On the left side (panel A), the
values for the ApoE–/– mice are shown, and on the right side
(panel B), the values for the ApoE–/–Fbn1C1039G+/– mice
can be found. For both cases, the status is pictured with
circles at week 15 and with crosses at week 20. A first striking
feature is that the contrast preferentially builds up near
the bifurcation and is more or less confined to this
region, especially for the ApoE–/–Fbn1C1039G+/– mice. For the
ECA, shown in the second row in Figure 7 (panels C and D),
the contrast agent is much less restricted to a specific region.
On an average basis, the locations are more or less uniform
along the inspected length of the artery. Finally, for the ICA,
shown in the third row in Figure 7 (panels E and F), the
contrast agent is mostly located near the bifurcation at
week 15, with a gradual decrease downstream. At week 20,
however, it evolved to a state where the Aurovist was more
equally distributed along the whole artery, confirming
earlier results.
Figure 5. Contrast-enhanced regions around the carotid bifurcation of
an ApoE–/– mouse at weeks 15 and 20 after the start of the diet. At week
15, both the medial side of the carotid bifurcation (A) and the lateral side
(B) only show small zones with little contrast enhancement. These zones
are preferably located at the external carotid artery (ECA). The contrast-
enhanced regions have grown over time and are at week 20 (C and D)
merely located in the ECA and internal carotid artery. They are mainly
situated at the medial side (C) compared to the lateral side (D).
Figure 6. Contrast-enhanced regions around the carotid bifurcation of
an ApoE–/–Fbn1C1039G+/– mouse at weeks 15 and 20. A and B, At week 15,
regions with contrast enhancement are visible in the last part of the
common carotid artery, in the first part of the internal carotid artery, and
along the external carotid artery (ECA). These regions span both the
medial (A) and the lateral (B) side of the carotid bifurcation. C and D,
At week 20, the area with contrast enhancement has increased. They are
still the same zones as at week 15, but they have grown considerably in
size. Especially in the ECA, contrast agent is present along the whole
length. The contrast agent is present around the whole bifurcation and
thus spans both the medial (C) and the lateral (D) side.
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Figure 7. Localization of Aurovist at the different branches. At the horizontal axis, the distance, sampled at 0.05 mm, from the bifurcation is
depicted, and on the vertical axis, the percentage of cases with Aurovist at that precise location is shown. The occurrence of Aurovist at every location
was determined by projecting the lumen surface contrast agent plot on the centerline. The first row (panels A and B) shows the common carotid
artery (CCA), the second row (panels C and D) the external carotid artery (ECA), and the third row (panels E and F) the internal carotid artery
(ICA). On the left-hand side (panels A, C, and D), the ApoE–/– mice, and on the right-hand side (panels B, D, and F), the ApoE–/–Fbn1C1039G+/– mice
are shown. For every case, the comparison was made between the situation at week 15 (circles) and week 20 (crosses).
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Discussion
In this study, we investigated contrast-enhanced, in vivo
microCT imaging to visualize macrophage infiltration over
time in murine atherosclerotic plaques. The technique was
validated with histology and applied in a longitudinal study
including both ApoE–/– mice, a model for stable athero-
sclerotic plaque, and ApoE–/–Fbn1C1039G+/– mice, a model
for vulnerable atherosclerotic plaque. We used two different
methods to quantify the contrast accumulated in the
atherosclerotic plaque: the CAF for the contrast-enhanced
area fraction and the CLF for the contrast-enhanced cen-
terline length fraction of the branches along the carotid
bifurcation. We visualized and quantified the different
contrast-enhanced locations and found significant differ-
ences in macrophage infiltration between time points and
between mouse models.
Contrast Agent Accumulation and Distribution
We observed significant growth in contrast-enhanced (and
thus macrophage-infiltrated) regions over time in both
mouse models, and these regions were significantly larger
in ApoE–/–Fbn1C1039G+/– mice compared to ApoE–/– mice.
Nevertheless, interesting geometric differences could
be observed between different branches. In the
ApoE–/–Fbn1C1039G+/– mice, the CAF and CLF increased
significantly from week 15 to week 20 at both the ICA and
the CCA, whereas only a small increase was noticeable at the
ECA. This could be explained by the fact that in about 75%
of the ApoE–/–Fbn1C1039G+/– mice, the contrast agent was
already present along the entire ECA at week 15. Therefore,
there was only little space for an expansion of the contrast-
enhanced region along the lumen over time as it occurred in
the other two branches. Another interesting observation in
this respect was that in both mouse models, at both time
points, a larger part of the ECA and the ICA was contrast
enhanced compared to the CCA. Moreover, the contrast-
enhanced regions in the CCA were localized near the bifur-
cation, whereas the contrast-enhanced regions in the ECA
and the ICA were smeared out away from the bifurcation.
Likely, the latter can be linked to flow hemodynamics
because locations of low and oscillatory flow are known to
promote macrophage infiltration.36,37 Since the flow distally
to the bifurcation is likely to be more disturbed, flow per-
turbations will induce more spread out flow patterns in the
ECA and ICA. In the CCA on the other hand, the blood flow
reaches a stagnation point at the bifurcation and few flow
perturbations occur upstream. We conclude that macro-
phage infiltration occurs with similar geometric patterns but
different intensities in both mouse models and that the ECA
is exposed to macrophage infiltration at an earlier time point
than the other two branches.
The study does not include control animals not devel-
oping atherosclerosis. Note, however, that the animals
included can, to a certain extent, be used as their own
controls. It is known that atherosclerosis develops only in a
later stage in the central section of the CCA. This is con-
sistent with our observation that no contrast accumulation is
visible in either ApoE–/– or ApoE–/–Fbn1C1039G+/– mice at
week 15 (Figure 7, A and Bddotted lines with circles) at the
proximal end of the CCA.
Advantages
Imaging Technique
The present methodology enabled the use of a high-
resolution microCT scanner for molecular imaging of the
location of macrophages in atherosclerotic plaques in the
carotid bifurcation of mice. This enables the measurement of
plaque development very precisely, which was not possible
with standard, purely anatomic microCT imaging. More-
over, it allows longitudinal in vivo studies of the inflam-
mation process in the artery wall in mice. Therefore, this
methodology has the potential to be used in preclinical
studies on plaque development or plaque-stabilizing ther-
apeutics. To the best of our knowledge, no such technique
currently exists in mice.
Postprocessing
The processing and quantification of the data have advan-
tages as well. We described a method to color-code
contrast-enhanced areas on the luminal surface, which gives
a clear overview of all the targeted areas (see Figure 5 and
Figure 6). This allows the demonstration of small location
shifts of the longitudinal data and is an excellent technique
to follow up individual cases. For example, in Figure 6, the
contrast-enhanced regions for the ApoE–/–Fbn1C1039G+/–
mouse clearly originate at the outer bends of the bifurcation
at week 15, but at week 20, they also span the inner side.
Another asset of this method is the user independency.
Only for the segmentation of the arterial geometry was
interaction of the user necessary by selecting points inside
the arterial network. The operator dependency study,
however, showed that operator dependency in this step is
likely to have only a very small influence on the resulting
CAF and the CLF values. For the more critical selection of
contrast-enhanced regions, no interaction was needed. In
the future, as segmentation and/or imaging techniques
evolve, the segmentation would probably evolve more
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toward automatic algorithms where (almost) no user
interaction will be needed.
Limitations
The main limitation of the scanning protocol is that two
microCT scans are needed, a pre- and a postcontrast injec-
tion scan, at every time point. First, this doubles the amount
of scans that have to be successful for one measurement data
set. Moreover, rigid image registration is an effective way of
removing translations between both scans, but it cannot
remove animal repositioning effects between the pre- and
the postcontrast injection scan at the same time point. In the
current study, this accounted for six failures of 50 mea-
surements. As such, measures to limit animal motion
between scans are warranted. The duration of every scan was
around 20 minutes, so one option is to reduce the scan time
by using another scan protocol or scanner to reduce the
amount of registration failures. Another option is to use a
more advanced registration method with more degrees of
freedom, for example, a deformable method, which can take
into account movements of the mouse.38
The repeated injections of Aurovist do not seem to have
an effect on the animal welfare23 or plaque development.
However, due to the need for pre- and postcontrast injection
scans, the animals receive twice as much radiation. In this
study, the mice were scanned six times, spread out over 10
weeks, with an estimated total radiation dose of 6 Gy.
Therefore, we cannot rule out radiation dose–induced
morbidity and mortality. It is therefore important to opti-
mize protocols in terms of radiation dose and number of
intermediate time points and to required image quality.
A larger sample size would result in a smoother curve
for the localization of the contrast agent in the different
branches (see Figure 7). The applied framework lacks
inherent information about the depth of the contrast accu-
mulations as long as they are closer than the threshold value
of 0.3 mm to the lumen surface. Therefore, it is a useful
tool to determine the size and location of the areas with
contrast agent but is less suited to study outward or inward
remodeling-related processes occurring in atherosclerotic
plaque development.
In the present study, there was a time difference of
5 weeks between consecutive measurements. The Aurovist
stayed inside the lumen for more than 24 hours but after-
wards gradually decreased. During this time, the Aurovist
was taken up by macrophages and migrated to the athero-
sclerotic plaque regions. However, it is possible that these
macrophages migrated and mixed with macrophages that
had migrated at a later time point.
Finally, we chose to express the contrast-enhanced
regions in terms of influenced luminal area and influenced
artery length. As a side effect of this choice, the inner curve
of the bifurcation can be taken into account twice. If the
curve is sharp enough, the surface normals of both the ECA
and the ICA will penetrate this region. However, this effect
plays a role only for a small fraction of the surface and does
not affect the meaning of the influenced area because this is
the transition between both branches.
Conclusion
We propose Aurovist-enhanced microCTas a promising new
tool to visualize macrophage infiltration in vivo in pre-
clinical small animal research. By using histology, we showed
that Aurovist coincides with macrophages using histology
and developed a methodology to quantify Aurovist presence
within atherosclerotic plaques based on in vivo microCT
images. We applied this methodology in a longitudinal
follow-up study in two different mouse models for athero-
sclerotic plaque. We observed a significant growth of
contrast-enhanced (and thus macrophage-infiltrated)
regions over time in both mouse models, and these regions
were significantly larger in ApoE–/–Fbn1C1039G+/– mice
(a model for vulnerable plaque) compared to ApoE–/– mice
(a model for stable plaque). Regional differences in macro-
phage distribution over different branches suggested that
local hemodynamics affect macrophage infiltration. The
developed methodology will be used in the future to perform
more in-depth research on the presence of macrophages in
cardiovascular disease in mice.
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